Marisa S Ghersi1, L A Gabach, F Buteler, A A Vilcaes, H B Schiöth, M F Perez, S R de Barioglio. 1. Dpto. de Farmacología, Facultad de Ciencias Químicas, Instituto de Farmacología Experimental de Córdoba, IFEC-CONICET, Universidad Nacional de Córdoba, Haya de la Torre y Medina Allende s/n, Ciudad Universitaria, 5000, Córdoba, Argentina, mghersi@fcq.unc.edu.ar.
Abstract
RATIONALE: Ghrelin (Ghr) is a peptide that participates in the modulation of several biological processes. Ghr administration into the hippocampus improves learning and memory in different memory tests. However, the possible mechanisms underlying this effect on memory have not yet been clarified. OBJECTIVE: The purpose of the present work is to add new insights about the mechanisms by which Ghr modulates long-term memory consolidation in the hippocampus. We examined Ghr effects upon processes related to increased synaptic efficacy as presynaptic glutamate release and changes in the expression of the NR2B-subunits containing n-methyl-d-aspartate receptors (NMDAR), which are critical for LTP induction. We also attempted to determine the temporal window in which Ghr administration induces memory facilitation and if the described effects depend on GHS-R1a stimulation. RESULTS: The present research demonstrated that Ghr increased glutamate release from hippocampal synaptosomes; intra-hippocampal Ghr administration increased NR2B-subunits expression in CA1 and DG subareas and also reversed the deleterious effects of the NR2B-subunit-specific antagonist, Ro 25-6981, upon memory consolidation and LTP generation in the hippocampus. These effects are likely to be the consequence of GHS-R1a activation. CONCLUSION: According to the results above mentioned and previous findings, we can hypothesize some of the mechanisms by which Ghr modulates memory consolidation. At presynaptic level, Ghr stimulates glutamate release, probably by enhancing [Ca(2+)]i. At postsynaptic level, the glutamate released activates NMDAR while Ghr also mediates effects directly activating its specific receptors and increases NR2B-subunit expression.
RATIONALE: Ghrelin (Ghr) is a peptide that participates in the modulation of several biological processes. Ghr administration into the hippocampus improves learning and memory in different memory tests. However, the possible mechanisms underlying this effect on memory have not yet been clarified. OBJECTIVE: The purpose of the present work is to add new insights about the mechanisms by which Ghr modulates long-term memory consolidation in the hippocampus. We examined Ghr effects upon processes related to increased synaptic efficacy as presynaptic glutamate release and changes in the expression of the NR2B-subunits containing n-methyl-d-aspartate receptors (NMDAR), which are critical for LTP induction. We also attempted to determine the temporal window in which Ghr administration induces memory facilitation and if the described effects depend on GHS-R1a stimulation. RESULTS: The present research demonstrated that Ghr increased glutamate release from hippocampal synaptosomes; intra-hippocampal Ghr administration increased NR2B-subunits expression in CA1 and DG subareas and also reversed the deleterious effects of the NR2B-subunit-specific antagonist, Ro 25-6981, upon memory consolidation and LTP generation in the hippocampus. These effects are likely to be the consequence of GHS-R1a activation. CONCLUSION: According to the results above mentioned and previous findings, we can hypothesize some of the mechanisms by which Ghr modulates memory consolidation. At presynaptic level, Ghr stimulates glutamate release, probably by enhancing [Ca(2+)]i. At postsynaptic level, the glutamate released activates NMDAR while Ghr also mediates effects directly activating its specific receptors and increases NR2B-subunit expression.
Authors: M A Bednarek; S D Feighner; S S Pong; K K McKee; D L Hreniuk; M V Silva; V A Warren; A D Howard; L H Van Der Ploeg; J V Heck Journal: J Med Chem Date: 2000-11-16 Impact factor: 7.446
Authors: K Ulrich Bayer; Eric LeBel; Greg L McDonald; Heather O'Leary; Howard Schulman; Paul De Koninck Journal: J Neurosci Date: 2006-01-25 Impact factor: 6.167
Authors: J E Brenman; D S Chao; S H Gee; A W McGee; S E Craven; D R Santillano; Z Wu; F Huang; H Xia; M F Peters; S C Froehner; D S Bredt Journal: Cell Date: 1996-03-08 Impact factor: 41.582
Authors: R Sprengel; B Suchanek; C Amico; R Brusa; N Burnashev; A Rozov; O Hvalby; V Jensen; O Paulsen; P Andersen; J J Kim; R F Thompson; W Sun; L C Webster; S G Grant; J Eilers; A Konnerth; J Li; J O McNamara; P H Seeburg Journal: Cell Date: 1998-01-23 Impact factor: 41.582
Authors: Jessica A Murphy; Ivar S Stein; C Geoffrey Lau; Rui T Peixoto; Teresa K Aman; Naoki Kaneko; Kelly Aromolaran; Jessica L Saulnier; Gabriela K Popescu; Bernardo L Sabatini; Johannes W Hell; R Suzanne Zukin Journal: J Neurosci Date: 2014-01-15 Impact factor: 6.167
Authors: Elia S Harmatz; Lauren Stone; Seh Hong Lim; Graham Lee; Anna McGrath; Barbara Gisabella; Xiaoyu Peng; Eliza Kosoy; Junmei Yao; Elizabeth Liu; Nuno J Machado; Veronica S Weiner; Warren Slocum; Rodrigo A Cunha; Ki A Goosens Journal: Biol Psychiatry Date: 2016-11-29 Impact factor: 13.382
Authors: Jörgen A Engel; Elisabet Jerlhag; Lennart Svensson; Roy G Smith; Emil Egecioglu Journal: Psychopharmacology (Berl) Date: 2015-08-29 Impact factor: 4.530